Pre Symposium Biostatistics Workshop (28 & 29 July)

Pre-Symposium Biostatistics Workshop on Advanced and Innovative Clinical Trial Designs

Please note:

• On 28-29 July 2026, there are two concurrent Pre-Symposium Workshops - Biostatistics as well as Health Technology Assessment.

• Availability for this Pre-Symposium Workshop is limited to 30 pax and registration will close once capacity is reached.

• Delegates who sign up for pre-symposium workshop will also enjoy complimentary access to the Main Symposium.

  

• This workshop is an Accredited CME Event approved by the Singapore Medical Council.
  Total: 8 Cat-1B CME Points (4 points for Day 1, 4 points for Day 2).
  CPE (For Nurses Only) is pending for approval.

  ---

This workshop, titled Advanced and Innovative Clinical Trial Designs, provides a comprehensive and practice-oriented introduction to the evolving landscape of clinical research methodology. With a specific focus on moving beyond traditional randomized controlled trials, this course explores advanced and adaptive strategies designed to improve trial efficiency, ethical standards, and statistical power.

Designed as a pre-symposium short course for the SCRI Clinical Trials Symposium 2026, the workshop aims to strengthen participants’ understanding of the entire research lifecycle from the logic of early-phase dose-finding to the intricacies of late-stage cluster and stepped-wedge designs. Participants will gain up-to-date insights into precision medicine trials and the integration of Artificial Intelligence (AI) in research. The curriculum is structured to bridge the gap between theoretical statistical concepts and practical application in real-world clinical settings.

The course is tailored for:

• Clinical Researchers and Investigators seeking to expand their portfolio with more efficient, adaptive, or patient-centric trial designs.

• Biostatisticians and Data Scientists wishing to update their methodological toolkit with a variety of techniques in sample size estimation, interim analysis, and AI applications.

• Pharmaceutical and Biotech Professionals engaged in drug development who need to optimize early-phase strategies (First-in-human, Phase I) and precision trial designs.

• Regulatory and Review Board Members who want to appreciate the scientific validity and ethical considerations of innovative, non-traditional trial designs.

The workshop is best suited for individuals with basic knowledge of clinical trial principles, fundamental biostatistics, and an interest in the practical implementation of novel research methodologies.

** Programme is subjected to changes without prior notification from the organiser

Biostatistics Workshop Speakers

About the SCRI Biostatistics Unit

SCRI’s Biostatistics team is a multidisciplinary group of statisticians and quantitative scientists who support the full lifecycle of clinical research from rigorous study design through to analysis, reporting, and knowledge translation. The team specialises in clinical trial design across all phases, sample‑size optimisation, randomisation generation, statistical analysis planning and programming, data standardisation to CDISC standards, and advanced data visualisation. They produce statistical analysis plans, regulatory‑quality statistical reports and manuscripts, and provide expert review for grant agencies, journals, ethics committees and industry partners. Through close collaboration with clinical teams across specialties, including oncology, diabetes, cardiovascular disease, infectious disease and eye care, the Biostatistics team strengthens evidence quality and reproducibility, enabling practice‑changing research and evidence‑based patient care. They also lead capacity building through consultations and workshops for clinicians and students in study design, analysis, and grant writing.